GLP-1 safety communications Archives - Pharma Marketing Network

Home Tags GLP-1 safety communications

GLP-1 injection pen, medication vial, and safety warning materials illustrating overdose concerns, dosing errors, and pharmaceutical risk communication challenges.

The GLP-1 Safety Reckoning: Why Overdose Headlines Are Becoming a Marketing...

Donna Pacheco - June 22, 2026

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

GLP-1 injection pen, medication vial, and safety warning materials illustrating overdose concerns, dosing errors, and pharmaceutical risk communication challenges.

The GLP-1 Safety Reckoning: Why Overdose Headlines Are Becoming a Marketing...

June 22, 2026

AI-powered pharmaceutical content generation contrasted with medical, legal, and regulatory review processes, illustrating the personalization bottleneck in pharma content operations.

The Personalization Bottleneck: Why AI Is Outpacing Pharma Operations

June 19, 2026

The Label Expansion Playbook: How Pharma Gives Established Brands a Second...

June 19, 2026